Recent reports show that Pyk2 is overexpressed in certain cancer cells, including non-small cell lung cancer, and higher Pyk2 activity is correlated with enhanced cell migration in A549 cells [52,53]. This evidence concerns the gene PTK2B and non-small cell lung carcinoma.